2010Journal of Clinical Pulmonary MedicineRequires access

The action of moxifloxacin in the elderly community-acquired pneumonia

Qiu Yue-lin

Open publisher page 0 citations

Abstract

Objective To evaluate the effectiveness and safety of moxifloxacin in the elderly community-acquired pneumonia.Methods The patients with elderly community-acquired pneumonia who were in hospital from January 2008 to March 2009 were randomly selected and divided into a treatment group(n=20)and a contrast group(n=20).The treatment group were given moxifloxacin 400 mg intravenous drip qd and the contrast group were given 300 mg of levofloxacin qd.The period of the treatment was two weeks.Clinical effects and adverse reactions were observed.Results The effective rates of the treatment group were 87.50%,the rates of bacterial clearance were 82.75%.The rates of adverse reactions were 12.50%.Conclusion Moxifloxacin in the elderly community-acquired pneumonia has high effective rates and less adverse reactions.

About this research paper

What this paper is about

Objective To evaluate the effectiveness and safety of moxifloxacin in the elderly community-acquired pneumonia.Methods The patients with elderly community-acquired pneumonia who were in hospital from January 2008 to March 2009 were randomly selected and divided into a treatment group(n=20)and a contrast group(n=20).The treatment group were given moxifloxacin 400 mg intravenous drip qd and the contrast group were given 300 mg of levofloxacin qd.The period of the treatment was two weeks.Clinical effects and adverse reactions were observed.Results The effective rates of the treatment group were 87.50%,the rates of bacterial clearance were 82.75%.The rates of adverse reactions were 12.50%.Conclusion Moxifloxacin in the elderly community-acquired pneumonia has high effective rates and less adverse reactions.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the effectiveness and safety of moxifloxacin in the elderly community-acquired pneumonia.Methods The patients with elderly community-acquired pneumonia who were in hospital from January 2008 to March 2009 were randomly selected and divided into a treatment group(n=20)and a contrast group(n=20).The treatment group were given moxifloxacin 400 mg intravenous drip qd and the contrast group were given 300 mg of levofloxacin qd.The period of the treatment was two weeks.Clinical effects and adverse reactions were observed.Results The effective rates of the treatment group were 87.50%,the rates of bacterial clearance were 82.75%.The rates of adverse reactions were 12.50%.Conclusion Moxifloxacin in the elderly community-acquired pneumonia has high effective rates and less adverse reactions.

Key concepts: Medicine, Moxifloxacin, Community-acquired pneumonia, Pneumonia, Levofloxacin, Adverse effect, Bacterial pneumonia, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
The action of moxifloxacin in the elderly community-acquired pneumonia — Research Paper | ScholarLens